title: Cohort analysis of FISH testing of CD138(+) cells in relapsed multiple myeloma: implications for prognosis and choice of therapy.
authors.affiliation: Department of Haematology, UCL Cancer Institute, London, UK. dean.smith@ucl.ac.uk.
authors.forename: Dean
authors.initials: D
authors.lastname: Smith
authors.affiliation: University College London, London, UK.
authors.forename: Clemency
authors.initials: C
authors.lastname: Stephenson
authors.affiliation: Department of Haematology, UCL Cancer Institute, London, UK.
authors.forename: Laura
authors.initials: L
authors.lastname: Percy
authors.affiliation: University College London, London, UK.
authors.forename: Anna
authors.initials: A
authors.lastname: Lach
authors.affiliation: Department of Cytogenetics, Great Ormond Street Hospital, London, UK.
authors.forename: Steve
authors.initials: S
authors.lastname: Chatters
authors.affiliation: Department of Cytogenetics, Great Ormond Street Hospital, London, UK.
authors.forename: Helena
authors.initials: H
authors.lastname: Kempski
authors.affiliation: Department of Haematology, UCL Cancer Institute, London, UK.
authors.forename: Kwee
authors.initials: K
authors.lastname: Yong
mesh_terms: D000328:Adult; D000368:Aged; D015331:Cohort Studies; D018450:Disease Progression; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D053208:Kaplan-Meier Estimate; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy / Q000276:immunology* / Q000401:mortality; D011379:Prognosis; D061988:Proteasome Inhibitors / Q000627:therapeutic use; D012008:Recurrence; D012307:Risk Factors; D053668:Syndecan-1 / Q000378:metabolism*
chemical_list: D061988:Proteasome Inhibitors; D053668:Syndecan-1
keywords: FISH; myeloma therapy; prognostic factors